Lead party: Life Ventures Holding (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Investor view in Meridian Capital
Target: Nawah Scientific Inc. (private company) · Sector: Healthcare, Biotechnology, Pharmaceuticals · Countries of operation: Egypt
Transaction type: Investment, Debt Financing · Asset class: Venture Capital · Strategy: Venture Equity, Venture Debt, Direct Lending · Instrument: Equity, Debt, Grant · Round: Series A · Deal amount: US$23m
Lead investor/buyer: Life Ventures Holding · Investors/buyers: Life Ventures Holding, Den Venture, M Empire Angels, AfricInvest Capital Partners LLC, Elsewedy Capital Holding, Angel Investors
Legal advisers: not identified in the source record.
Source: announced 18 December 2025. Original announcement: wamda.com.


